VRNA
$21.46
Verona Pharma Plc ADR
($.42)
(1.92%)
VRNA
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.26)
Revenue:  N/A
Tuesday
Aug 8
2:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VRNA reports earnings?
Beat
Meet
Miss

Where is VRNA's stock price going from here?
Up
Flat
Down
Stock chart of VRNA
Analysts
Summary of analysts' recommendations for VRNA
Score
Grade
Pivots
Resistance
$23.39
$22.83
$22.14

$21.58

Support
$20.89
$20.33
$19.64
Tweet
Growth
Description
Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.
›